Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Simon Farrell Create: Alert

All | News | Filings
Date FiledTypeDescription
03/08/2023 4 Simon Farrell (Chief Commercial Officer) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Exercised 18,750 options to buy @ $0.511, valued at $9.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy